期刊文献+

定量检测人超敏C-反应蛋白双抗体夹心ELISA方法的建立及初步临床应用 被引量:3

Establishment of a sandwich ELISA for quantitative measurement of human supersensitivity C-reactive protein and primary clinical application study
下载PDF
导出
摘要 目的:建立定量检测人超敏C-反应蛋白(CRP)双抗体夹心EUSA方法。方法:采用Protein A亲和层析法纯化本室制备的抗CRP单克隆抗体(mAbs),并行SDS—PAGE和Western blotting对纯化抗体特性进行鉴定;利用简易过碘酸钠法对抗CRPmAbs进行标记HRP后行抗体配对实验;通过方阵滴定法确定包被抗体和酶标抗体的最适工作浓度;以纯化的CRP抗原为标准品建立标准曲线;以重复性、灵敏性和回收率实验评价ELISA方法。初步对人血浆中的超敏CRP水平进行检测。结果:最佳配对组合为抗CRP mAb 1C10和HRP标记的抗CRP mAb2 C11,最适工作浓度分别为10μg/mL和l:2000,该方法的批内、批间变异系数分别为3.1%~9.7%和3.6%~13.6%,灵敏度达8.3ng/mL,回收率为90%~109%。用ELISA法测定左右冠无明显狭窄者68例,狭窄小于50%者59例和狭窄大于50%患者67例的血浆hs.CRP水平,冠脉狭窄小于50%组(3.7±1.2)mg/L与冠脉无狭窄组(1.8±0.7)mg/L比较明显升高(P〈0.05);狭窄大于50%组(8.9±3.3)mg/L与狭窄小于50%组比较明显升高(P〈0.05)。结论:建立了一种可用于检测人超敏CRP的双抗体夹心ELISA方法。 AIM: To establish a sandwich EHSA for quantitative measurement of supersensitivity C-reactive protein(hs-CRP). METHODS: Anti-CRP monoclonal antibodies (mAbs) prepared by our laboratory were purified by Protein A affinity chromatography and analyzed by SDS-PAGE and Western-blotting to test their characteristics. All the mAbs were labeled with horseradish peroxidase by sodium oxidation method and antibody mating test were performed using anti-CRP mAb as coating antibody and HRP labeled anti-CRP mAb as labeled antibody, in which optimal concentrations were defined by square mateix titration. Standard curve was performed using purified CRP and the sensitivity, reproducibility and recovery rate test of ELISA was evaluated. The ClIP levels in plasma were measured in this assay. RESULTS: The optimal paired antibodies were anti-CRP mAb 1C10 and HRP labeled anti-CRP mAb 2Cll, and the optimal concentrations were 10 μg/mL and 1 : 2000, respectively. The coefficient of variation were 3.1% to 9.7% within assay and 3.6 % to 13.6 % between assay. The sensitivity in this assay was 8.3 ng/mL. The recovery rate was 90 % to 109%. According to the result, 68 normal persons' hs-CRP level in plasma of coronary arteriography were detected by ELISA, 59 with stenosis 〈 50% and 67 with stenosis ≥ 50%. The results showed that the plasma hs-CRP level in patients with stenosis 〈 50% (3.65 ± 1.15) mg/L was significantly higher( P 〈 0.05) than hs-CRP in normol persons( 1.75 ± 0.74) mg/L, the plasma hs-CRP level in stenosis ≥ 50% patients (8.93 ± 3.29) mg/L was significantly higher (P 〈 0.05) than stenosis 〈 50% patients. CONCLUSION: A sandwich ELISA for detecting hs-CRP was established.
出处 《中国临床药理学与治疗学》 CAS CSCD 2009年第1期84-89,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 重大疾病分子诊断和生物治疗的高技术平台基金项目(XK200705)
关键词 定量检测 超敏C-反应蛋白 ELISA双抗体夹心法 quantitative measurement hs-CRP sandwich EHSA
  • 相关文献

参考文献12

  • 1Steven B, Irving K, David S. C-reactive protein[J]. J Biol Chem, 2004,279(47) :48487 - 48490.
  • 2Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation [ J ]. N Engl J Med, 1999,340(6) :448 - 454.
  • 3Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link[J]? Atherosclerosis, 2000, 148(2):209 - 214.
  • 4Chang MK, Binder C J, Torzewski M, et al. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: pbosphorylcholine of oxidized phospholipids [ J]. Proc Acad Sci U S A, 2002,99(20) : 13043 - 13048.
  • 5Ridker PM. C-reactive protein and the predition of cardiovascular events among those at intermediate risk : moving an inflammatory hypothesis toward consensus [ J ]. J Am Coll Cardiol, 2007,49(21 ) :2129 - 2138.
  • 6Bansal S, Ridker PM. Comparison of characteristics of future myocardial infarction in women with baseline high versus baseline low levels of hs-C-reactive protein[J]. Am J Cardiol, 2007,99( 11 ) : 1500 - 1503.
  • 7Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention [ J ]. Circulation, 2003,107(3) :363 - 369.
  • 8Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [ J]. N Engl J Med, 2000,342(12) : 836 - 843.
  • 9Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease [ J ]. Circulation, 2001, 103 (13):1813- 1818.
  • 10Piscbon T, Hu FB, Rexrode KM, et al. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men[J ]. Atherosclerosis, 2008, 197 ( 1 ) : 392 - 399.

同被引文献21

  • 1吴添沐,吴松鹰.C反应蛋白与脑梗死相关性的研究进展[J].医学综述,2007,13(7):525-527. 被引量:13
  • 2Hind CR,Thomson SP,Winearls CG, et al. Serum C -reactive protein concentration in the management of infection in patients treated by continuous ambulatory peritoneal dialysis [J]. J Clinpathol, 2004,38(4) :459-463.
  • 3Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a post traumatic chronic subdural hematoma: a prospective study[J]. J Neurosurg, 2004,100(1) :24-32.
  • 4Beeton CA, Chatfield D, Brooks RA, et al. Circulating levels of interleukin in-6 and its soluble receptor in patients with head injury and fracture[J]. J Bone Jo int Surg Br, 2004,86(6):912- 17.
  • 5Wilcockson DC, Campbell SJ, Anthony DC, et al. The systemic and local acute phase response following acute brain injury[J]. J Cereb Blood Flow Metab, 2002,22(3):318- 326.
  • 6Oeonnor E, Venkatesh B, Mashongonyika C, et al. Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage [J]. Anaesth Intensive Care, 2004,32(4) :465-470.
  • 7Diringer M. Reducing neurologic injury from hyperthermia(A hot topic)[J]. Neurology, 2001,56(3): 286 -287.
  • 8Mayer SA, Commichau C, Searmeas N, et al. Clinical trial of an aireireulating cooling blanket for fever control in critically ill neurological patients[J]. Neurology, 2001,56(3) :292-298.
  • 9Kammersgaard LP, Rsamussen BH, Jorgensen HS, et al. Feasibility and safety of inducing modest hypoter mia in awak patients with acute stroke throught surface cooling[J]. Stroke, 2000, 31 (9) :2251- 2259.
  • 10Bayir H,Clark RS,Kochanek PM. Promising strategies to minimize secondary brain injuryafter head trauma[J].Crit Care Med,2003,31(suppl 1):s112-s117.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部